Abstract:Poorly water-soluble weakly basic compounds which are solubilized in gastric fluid are likely to precipitate after the solution empties from the stomach into the small intestine, leading to a low oral bioavailability. In this study, we reported an approach of combining solubilization agents and precipitation inhibitors to produce a supersaturated drug concentration and to prolong such a drug concentration for an extended period of time for an optimal absorption, thereby improving oral bioavailability of poorly water-soluble drugs. A weakly basic compound from Johnson and Johnson Pharmaceutical Research and Development was used as a model compound. A parallel microscreening precipitation method using 96-well plates and a TECAN robot was used to assess the precipitation of the tested compound in the simulated gastric fluid (SGF) and the simulated intestinal fluid (SIF), respectively, for lead solubilizing agents and precipitation inhibitors. The precipitation screening results showed vitamin E TPGS was an effective solubilizing agent and Pluronic F127 was a potent precipitation inhibitor for the tested compound. Interestingly, the combination of Pluronic F127 with vitamin E TPGS resulted in a synergistic effect in prolonging compound concentration upon dilution in SIF. In addition, HPMC E5 and Eudragit L100-55 were found to be effective precipitation inhibitors for the tested compounds in SGF. Furthermore, optimization DOE study results suggested a formulation sweet spot comprising HPMC, Eudragit L 100-55, vitamin E TPGS, and Pluronic F127. The lead formulation maintained the tested compound concentration at 300 μg/mL upon dilution in SIF, and more than 70% of the compound remained solubilized compared with the compound alone at <1 μg/mL of its concentration. Dosing of the solid dosage form predissolved in SGF in dogs resulted in 52% of oral bioavailability compared to 26% for the suspension control, a statistically significant increase (p = 0.002). The enhanced oral bioavailability of the tested compound could be attributed to generation and prolongation of a supersaturated drug concentration in vivo by the solubilizing agents and precipitation inhibitors. The study demonstrates that the combination approach of solubilization agents and precipitation inhibitors provides improved oral bioavailability for a poorly water-soluble weakly basic compound.

Pellets of Phospholipids and D-Glucose with Improved Intestinal Absorption and Oral Bioavailability of Salvianolic Acid B

Bioavailability and Foam Cells Permeability Enhancement of Salvianolic Acid B Pellets Based on Drug–phospholipids Complex Technique

Glycyrrhizic Acid-Phospholipid Complex: Preparation Process Optimization and Therapeutic and Pharmacokinetic Evaluation in Rats

Mechanisms of Phospholipid Complex Loaded Nanoparticles Enhancing the Oral Bioavailability

Enhanced Bioavailability of the Poorly Water-Soluble Drug Fenofibrate by Using Liposomes Containing a Bile Salt

The use of PEGylated liposomes to prolong the circulation lifetime of salvianolic acid B

Extra virgin olive oil-based phospholipid complex/self-microemulsion enhances oral absorption of salvianolic acid B through inhibition of catechol-O-methyltransferase-mediated metabolism

Preparation and IVIVC evaluation of salvianolic acid B micro-porous osmotic pump pellets

Binary lipids-based nanostructured lipid carriers for improved oral bioavailability of silymarin.

A Lipophilic Prodrug of Danshensu: Preparation, Characterization, and in Vitro and in Vivo Evaluation

Integrity and stability of oral liposomes containing bile salts studied in simulated and ex vivo gastrointestinal media.

Oral Delivery of Decanoic Acid Conjugated Plant Protein Shell Incorporating Hybrid Nanosystem Leverage Intestinal Absorption of Polyphenols.

Improvement of oral bioavailability of glycyrrhizin by sodium deoxycholate/phospholipid-mixed nanomicelles

Preparation and Characterization of Syringic Acid–Loaded TPGS Liposome with Enhanced Oral Bioavailability and in Vivo Antioxidant Efficiency

Mechanism of enhanced oral absorption of akebia saponin D by a self-nanoemulsifying drug delivery system loaded with phospholipid complex

Mechanisms Of Oral Absorption Improvement For Insoluble Drugs By The Combination Of Phospholipid Complex And Snedds

Prescription Optimization and Oral bioavailability Study of Salvianolic Acid Extracts W/O/W Multiple Emulsion.

Diammonium Glycyrrhizinate-Based Micelles for Improving the Hepatoprotective Effect of Baicalin: Characterization and Biopharmaceutical Study

Enhanced bioavailability of a poorly water-soluble weakly basic compound using a combination approach of solubilization agents and precipitation inhibitors: a case study

Improvement of Oral Availability of Ginseng Fruit Saponins by a Proliposome Delivery System Containing Sodium Deoxycholate

Oral Absorption Enhancement of Probucol by Pegylated G5 Pamam Dendrimer Modified Nanoliposomes